BIOMAT Database Logo BIOMAT Database Logo

Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis. 1978

P Steele, and J Ellis, and E Genton

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005032 Ethylestrenol An anabolic steroid with some progestational activity and little androgenic effect. Ethyloestrenol,Maxibolin
D005260 Female Females

Related Publications

P Steele, and J Ellis, and E Genton
[Fibrinolytic and anticoagulant therapy of acute deep venous thrombosis (proceedings)].
January 1976, Acta medica Austriaca. Supplement,
P Steele, and J Ellis, and E Genton
[Therapy of thrombosis: anticoagulant-fibrinolytic therapy].
May 1986, Nihon rinsho. Japanese journal of clinical medicine,
P Steele, and J Ellis, and E Genton
Long-term anticoagulant therapy in patients with venous thrombosis.
November 1983, Archives of internal medicine,
P Steele, and J Ellis, and E Genton
[Fibrinolytic therapy of venous thrombosis].
October 1971, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
P Steele, and J Ellis, and E Genton
Venous thrombosis and anticoagulant therapy.
August 2001, British journal of haematology,
P Steele, and J Ellis, and E Genton
Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.
March 2001, Thrombosis and haemostasis,
P Steele, and J Ellis, and E Genton
Fibrinolytic therapy for venous thrombosis.
January 1991, Progress in cardiovascular diseases,
P Steele, and J Ellis, and E Genton
Fibrinolytic therapy and deep venous thrombosis.
June 1972, British medical journal,
P Steele, and J Ellis, and E Genton
[Anticoagulant therapy of venous thrombosis].
October 1952, Minerva medica,
P Steele, and J Ellis, and E Genton
[Fibrinolytic therapy of acute venous thrombosis].
January 1990, Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress,
Copied contents to your clipboard!